Serum Metabolite Concentrations and Decreased GFR in the General Population

Goek, Oemer-Necmi, Döring, Angela, Gieger, Christian, Heier, Margit, Koenig, Wolfgang, Prehn, Cornelia, Römisch-Margl, Werner, Wang-Sattler, Rui +7 more·2012·American Journal of Kidney Diseases

Cited by (121)

Items 101–121 of 121

  1. Metabolite Markers of Incident CKD Risk
    Eugene P. Rhee, Harold I. Feldman · 2014 · Clinical Journal of the American Society of Nephrology
  2. Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort
    Fayth M. Butler, Roy O. Mathew, Lars E. Sveen, Gary E. Fraser · 2025 · Journal of renal nutrition
  3. Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease
    Valeriia Dotsenko, Hana Hien Le, Sonja Rajić, Robert Moulder, Jalmari Kettunen, M. Karoliina Hirvonen, Alex M. Dickens, Tuulia Hyötyläinen, Bernhard Tewes, Timo Zimmermann et al. · 2026 · BMC Medicine
  4. Carnitine dysregulation in diabetic kidney disease: from pathogenic mechanism to precision biomarker
    Yuanhua Dai, Shiru Duan, Yuxi Li, Jin Rong, H Q Li, Weiping Su, Xiaoya Wu, Xiaoyu Peng, Huiming Qi, Shunmei Liu et al. · 2026 · Journal of Translational Medicine
  5. Tryptophan Metabolites Target Transmembrane and Immunoglobulin Domain-Containing 1 Signaling to Augment Renal Tubular Injury
    Mostafa Belghasem, Wenqing Yin, Saran Lotfollahzadeh, Xiaosheng Yang, Rosana Meyer, Marc Arthur Napoleon, Isaac E. Sellinger, Aniket Vazirani, Elena Metrikova, Asha Jose et al. · 2023 · American Journal Of Pathology
  6. Trans‐Omics Integration Reveals That the Kidney Contributes to Systemic Aging via Sexually Dimorphic Accumulation of Glycosphingolipids
    Zhen Ni, Chenyin Cao, Yanlin Tian, Jinming Mu, He Tian, Zehua Wang, Shaohua Zhang, Mingjun Cao, Yuntian Yang, Wei Ling Florence Lim et al. · 2026 · MedComm
  7. Serum Metabolomic Profiling and Incident CKD among
    Bing Yu, Yan Zheng, Jennifer A. Nettleton, Danny C. Alexander, Josef Coresh, Eric Boerwinkle · 2014
  8. The Role of Metabolomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools
    Uwe Christians, Jelena Klawitter, Jacek Klepacki, Jelena Klawitter · 2016 · Elsevier eBooks
  9. Activating PPARβ/δ-Mediated Fatty Acid β-Oxidation Mitigates Mitochondrial Dysfunction Co-induced by Environmentally Relevant Levels of Molybdenum and Cadmium in Duck Kidneys
    Jiamei Zhu, Gaohui Nie, Xueyan Dai, Dianyun Wang, ShanXin Li, Caiying Zhang · 2024 · Biological Trace Element Research
  10. The genomic architecture of blood metabolites based on a decade of genome-wide analyses
    Fiona A. Hagenbeek, René Pool, Jenny van Dongen, Harmen H. M. Draisma, Jouke‐Jan Hottenga, Gonneke A. H. M. Willemsen, Abdel Abdellaoui, Iryna O. Fedko, Anouk den Braber, Pieter Jelle Visser et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Application of Metabolomics to Cardiovascular and Renal Disease Biomarker Discovery
    Gloria Álvarez‐Llamas, María G. Barderas, María Posada-Ayala, Marta Martin‐Lorenzo, Fernando Vivanco · 2014 · Comprehensive analytical chemistry
  12. Novel biomarker panels in diabetic kidney disease
    Michelle J. Pena · 2015
  13. The genetic communication and interaction between chronic kidney diseases and frailty
    Xiaojun Wang, Xuchao Gu, Yuxin Zhang, Zhijun Bao · 2023 · Clinical and Translational Discovery
  14. Withdrawn: Combinatorial lipidomics and proteomics underscore erythrocyte lipid membrane aberrations in the development of adverse cardio-cerebrovascular complications in maintenance hemodialysis patients
    Ke Zheng, Yujun Qian, Haiyun Wang, Dan Song, Hui You, Bo Hou, Fei Han, Yi‐Cheng Zhu, Feng Feng, Sin Man Lam et al. · 2024 · Redox Biology · Retracted
  15. Development of a Heart-Cut Two-Dimensional Liquid Chromatography Method for Guanidinosuccinic Acid, Guanidinoacetic Acid and Guanidinobutyric Acid in Biological Samples
    Ke-ming Ning, Rong-Ju Yang, Dandan Guo, Quan Zhou, Zhao‐Ying Liu · 2025 · SSRN Electronic Journal
  16. Therapeutic Restoration of Systemic Multiomic Responses by Transglutaminase 2 inhibitor in Celiac Disease: A Gluten Challenge Approach
    Valeriia Dotsenko, Hana Hien Le, Sonja Rajić, Robert Moulder, Jalmari Kettunen, M. Karoliina Hirvonen, Alex M. Dickens, Tuulia Hyötyläinen, Bernhard Tewes, Timo Zimmermann et al. · 2025 · medRxiv
  17. Association of metabolomics measurements with blood cell phenotypes
    Brian D. Chen, Amanda L. Tapia, Eric Boerwinkle, Clary B. Clish, Robert Edgardo Gerszten, Mariaelisa Graff, Karen L. Mohlke, Alanna C. Morrison, Wimal Pathmasiri, Stephen S. Rich et al. · 2025 · Blood Cells Molecules and Diseases
  18. Additional file 1 of The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus
    Xuerui Li, Yuyang Miao, Fang, Zhongze, Zhang, Qiang · 2023 · Figshare
  19. The KD Atlas: A Multi-Omics Network Resource for Kidney Disease Research
    Yacoub Abelard Njipouombe Nsangou, Stefan Haug, Maria A. Wörheide, Orhan Bellur, Werner Römisch‐Margl, Jürgen Dönitz, Anna Köttgen, Matthias Arnold, Gabi Kastenmüller · 2026 · medRxiv
  20. Biomarqueurs diagnostiques et pronostiques au cours de la dysfonction du greffon rénal
    Marie‐Bénédicte Matignon · 2014
  21. Serum Metabolomic Profiling Reveals Distinct Signatures and Candidate Biomarkers in Chronic Kidney Disease
    Huimin Jin, Yun Gao, Haochen Zhang, Hanbing Li, Wenqi Wang, Ka Zhang, Fenghua Zhang · 2026 · International Journal of Nephrology and Renovascular Disease